Personalized medicine, says this article in T he Scientist , could breathe new life into failed drug candidates . “If Merck could have known in advance who would have cardiovascular problems from Vioxx, they may not have had to withdraw it from the market,” Personalized Medicine Coalition’s Edward Abrahams says.
A 2nd Loss For Merck Over Vioxx
A N.J. jury found that the company had not properly warned patients of the dangers of its drug Vioxx.
Merck Wins Extension to Appeal Vioxx Certification in Ontario
May 11 (Bloomberg) -- Merck & Co. won an extension to appeal the certification of an Ontario group lawsuit, claiming the painkiller Vioxx caused heart attacks and strokes, because certification of a similar suit was overturned in Saskatchewan. Click here for more infoTRENTON — The judge presiding over a Vioxx personal-injury trial in Atlantic City on Monday rejected a motion to give one of the two plaintiffs a second shot at winning damages from drugmaker Merck & Co.
Contact:
Copyright © 2005 Vioxx Advisor.com All Rights Reserved